Home/Filings/4/0001516551-21-000025
4//SEC Filing

Ward Keith Wayne 4

Accession 0001516551-21-000025

CIK 0001516551other

Filed

Dec 15, 7:00 PM ET

Accepted

Dec 16, 6:50 PM ET

Size

348.6 KB

Accession

0001516551-21-000025

Insider Transaction Report

Form 4
Period: 2021-12-14
Transactions
  • Award

    Director Option Grant (Right to Buy)

    2021-12-14+250,000250,000 total
    Exercise: $0.06Exp: 2031-12-14Common Stock (250,000 underlying)
Footnotes (1)
  • [F1]The Option grant shall be exercisable for a price of $0.058 per Option Share for ten years from December 14, 2021 (the "Grant Date") and the Options will vest in equal monthly installments over the one year period from the Grant Date.

Issuer

Skye Bioscience, Inc.

CIK 0001516551

Entity typeother

Related Parties

1
  • filerCIK 0001662394

Filing Metadata

Form type
4
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 6:50 PM ET
Size
348.6 KB